Blog
The success of an immunotherapy program can depend on questions that ordinary tumor-growth studies cannot answer alone. Researchers may need to understand immune-cell activity, tumor–immune
October 28, 2026
No Comments
The success of an immunotherapy program can depend on questions that ordinary tumor-growth studies cannot answer alone. Researchers may need to understand immune-cell activity, tumor–immune
Cancer drug development involves a chain of decisions in which early experimental evidence can shape later investment, study design, and clinical strategy. Outsourcing selected research
Cancer drug development rarely follows a straight path from promising laboratory findings to clinical testing. The value of early evidence depends heavily on whether the
